Kashif A W, Ranjan Akhil, Kalra Suprita, Shravani Uttpal Datta, Malik Ajay
Assistant Professor, Department of Pathology, Armed Forces Medical College, Pune, India.
Medial Cadet, Armed Forces Medical College, Pune, India.
Med J Armed Forces India. 2022 Jul;78(3):291-295. doi: 10.1016/j.mjafi.2020.11.004. Epub 2020 Dec 16.
Idiopathic steroid-resistant nephrotic syndrome (iSRNS) is a common problem in pediatric nephrology. About 10%-20% of children with nephrotic syndrome have iSRNS and almost 50 percent progress to end-stage renal disease. Very few studies have tried to study the histopathological spectrum, correlate clinical features, renal biopsy patterns and treatment outcome in children presenting with iSRNS in India. In this study, we compared the histopathologic distribution of different subtypes of glomerular morphologic patterns in iSRNS and the clinical and biochemical parameters at the time of diagnosis and outcome of patients after immunosuppressive therapy.
It is a retrospective cross-sectional study involving review of records of all children with iSRNS presenting to our pediatric nephrology OPD who underwent renal needle biopsy and followed-up for a period of atleast six months post biopsy. Histopathological subtypes were correlated with clinical features (viz. age of onset, gender, oliguria, microscopic hematuria, hypertension, serum creatinine at presentation, serum total protein, serum albumin, 24 h urine protein, persistent proteinuria after 12 weeks of calcineurin inhibitor therapy, and progress to end stage renal disease (ERSD), if any, outcome.
It was found that minimal change disease (MCD) was overall the most common cause of iSRNS. These patients have a significantly greater incidence of remission with immunosuppression as compared with focal segmental glomerulosclerosis (FSGS) and IgA nephropathy subgroup.
Kidney biopsy is of prognostic value in children with iSRNS. The prognosis of children with SRNS owing to MCD is much better than with other nephropathy.
特发性类固醇抵抗性肾病综合征(iSRNS)是儿科肾脏病学中的常见问题。肾病综合征患儿中约10%-20%患有iSRNS,近50%会进展为终末期肾病。在印度,很少有研究试图探讨iSRNS患儿的组织病理学谱、临床特征、肾活检模式与治疗结果之间的相关性。在本研究中,我们比较了iSRNS中不同亚型肾小球形态学模式的组织病理学分布,以及诊断时的临床和生化参数与免疫抑制治疗后患者的结局。
这是一项回顾性横断面研究,涉及对所有到我们儿科肾脏病门诊就诊并接受肾穿刺活检且活检后至少随访6个月的iSRNS患儿的记录进行回顾。组织病理学亚型与临床特征(即发病年龄、性别、少尿、镜下血尿、高血压、就诊时的血清肌酐、血清总蛋白、血清白蛋白、24小时尿蛋白、钙调神经磷酸酶抑制剂治疗12周后的持续性蛋白尿,以及是否进展至终末期肾病(ERSD))相关。
发现微小病变病(MCD)总体上是iSRNS最常见的病因。与局灶节段性肾小球硬化(FSGS)和IgA肾病亚组相比,这些患者免疫抑制治疗后缓解的发生率显著更高。
肾活检对iSRNS患儿具有预后价值。由MCD引起的SRNS患儿的预后比其他肾病要好得多。